Drug intelligence / Profile preview

ClinOleic + Omegaven

Development stage
Unknown
Lead developer
Takeda
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

ClinOleic + Omegaven is an intravenous lipid emulsion combination used primarily in parenteral nutrition for the prevention and treatment of parenteral nutrition-associated cholestasis (PNAC) and intestinal failure-associated liver disease (IFALD), especially in neonates and pediatric patients. The mixture typically combines olive oil/soybean oil-based lipids (ClinOleic) with fish oil-based lipids rich in omega-3 fatty acids (Omegaven), often at a 1:1 or 2:1 ratio. This combination provides essential fatty acids while reducing the risk of liver complications associated with traditional soybean oil-based emulsions. Mechanistically, it supplies energy, essential fatty acids, and modulates inflammatory responses by altering the balance of omega-6 to omega-3 polyunsaturated fatty acids. Clinical studies have shown improved outcomes in infants with short bowel syndrome or IFALD when using this combination compared to standard lipid emulsions[2][3][7].

Other names
ClinOleic/Omegaven mixtureOmegaven-Clinoleic Emulsion

Beyond the preview

Go deeper on ClinOleic + Omegaven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClinOleic + Omegaven.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call